The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Tarabrin A.S.

Bauman Municipal Hospital No. 29

Maksimkin D.A.

Peoples’ Friendship University of Russia

Pavkina A.A.

Pirogov Russian National Research Medical University

Khovalkin R.G.

Bauman Municipal Hospital No. 29

Zheltov N.Yu.

Bauman Municipal Hospital No. 29

Shugushev Z.Kh.

Peoples’ Friendship University of Russia

Endovascular interventions in patients with glass iii infrainguinal arterial disease: 2-year results

Authors:

Tarabrin A.S., Maksimkin D.A., Pavkina A.A., Khovalkin R.G., Zheltov N.Yu., Shugushev Z.Kh.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2022;(3): 70‑78

Read: 2231 times


To cite this article:

Tarabrin AS, Maksimkin DA, Pavkina AA, Khovalkin RG, Zheltov NYu, Shugushev ZKh. Endovascular interventions in patients with glass iii infrainguinal arterial disease: 2-year results. Pirogov Russian Journal of Surgery. 2022;(3):70‑78. (In Russ.)
https://doi.org/10.17116/hirurgia202203170

Recommended articles:

References:

  1. Vossen RJ, Philipszoon PC, Vahl A Cetal. A Comparative Cost-Effectiveness Analysis of Percutaneous Transluminal Angioplasty With Optional Stenting and Femoropopliteal Bypass Surgery for Medium-Length TASC II B and C Femoropopliteal Lesions. J Endovasc Ther. 2019;26(2):172-180.PMID: 30898070. https://doi.org/10.1177/1526602819833646
  2. Iida O, Urasawa K, Komura Y, Soga Y, Inoue N, Hara H, Yajima J, Nakamura S, Ohki T, Ando H, Hirano K, Horita Y, Kichikawa K, Yokoi Y, Miyamoto A, Nakamura M, Takahara M, Mano T, Nanto S. Self-Expanding Nitinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data From the SM-01 Trial. J EndovascTher. 2019;26(2):158-167. Epub 2019 Jan 31. PMID: 30702021. https://doi.org/10.1177/1526602819826591
  3. Dake MD, Ansel GM, Jaff MR, et al; Zilver PTX Investigators. Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial. Circulation. 2016;133:1472-1483. Epub 2016 Mar 11.  https://doi.org/10.1161/CIRCULATIONAHA.115.016900
  4. Laird JR, Schneider PA, Tepe G, et al. Sustained durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA. J Am CollCardiol. 2015;66:2329-2338. Epub 2015 Oct 14.  https://doi.org/10.1016/j.jacc.2015.09.063
  5. Rosenfield K, Jaff MR, White CJ. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med. 2015;373:145-153. Epub 2015 Jun 24.  https://doi.org/10.1056/NEJMoa1406235
  6. Norgren L, Hiatt WR, Dormandy JA et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33:1-75. Epub 2006 Nov 29.  https://doi.org/10.1016/j.ejvs.2006.09.024
  7. Dake MD, Ansel GM, Jaff MR, et al. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am CollCardiol. 2013;61:2417-2427. Epub 2013 Apr 10.  https://doi.org/10.1016/j.jacc.2013.03.034
  8. Dake MD, Scheinert D, Tepe G, et al. Zilver PTX Single-Arm Study Investigators. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther. 2011;18:613-623.  https://doi.org/10.1583/11-3560.1
  9. Kichikawa K, Ichihashi S, Yokoi H et al. Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results. Cardiovasc Intervent Radiol. 2019;42(3):358-364. Epub 2018 Nov 8.  https://doi.org/10.1007/s00270-018-2110-1
  10. Conte MS, Bradbury AW, Kolh P, et al. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. Guideline Clinical Practice document. 2019;58(1):1-109. Epub 2019 Jun 08.  https://doi.org/10.1016/j.ejvs.2019.05.006
  11. Mills JL, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI). Journal of Vascular Surgery. 2014;59(1):220-234.e2. Epub 2013 Oct 12.  https://doi.org/10.1016/j.jvs.2013.08.003
  12. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116:1509-1526. https://doi.org/10.1161/CIRCRESAHA.116.303849
  13. Conte MS. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia. J Vasc Surg. 2010;51:69-75.  https://doi.org/10.1016/j.jvs.2010.02.001
  14. Dosluoglu HH, et al. Clinical presentation and outcome after failed infrainguinal endovascular and open revascularization in patients with chronic limb ischemia. J Vasc Surg. 2013;58(1):98-104.e1.  https://doi.org/10.1016/j.jvs.2012.12.076
  15. Bosiers M, Setacci C, De Donato G, Torsello G, Silveira PG, Deloose K, Scheinert D, Veroux P, Hendriks J, Maene L, Keirse K, Navarro T, Callaert J, Eckstein HH, Teβarek J, Giaquinta A, Wauters J. ZILVERPASS Study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal Lesions. J Endovasc Ther. 2020;27(2):287-295. Epub 2020 Jan 30.  https://doi.org/10.1177/1526602820902014
  16. Geraghty PJ, Mewissen MW, Jaff MR. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis verses bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg. 2013;58:386-395. Epub 2013 May 13.  https://doi.org/10.1016/j.jvs.2013.01.050
  17. Rutherford RB, Baker JD, Calvin E, et al. Recommended standards for reports dealing with lower extremity ischemia: Revised version. Journal of Vascular Surgery. 1997;26(3):517-538.  https://doi.org/10.1016/S0741-5214(97)70045-4
  18. Biancari F, Albäck A, Ihlberg L, Kantonen I, Luther M, Lepäntalo M. Angiographic runoff score as a predictor of outcome following femorocrural bypass surgery. Eur J Vasc Endovasc Surg. 1999;17(6):480-485.  https://doi.org/10.1053/ejvs.1999.0825
  19. Tarabrin AS, Kuznetsov MR, Khovalkin RG, Zheltov NYu, Seleznev VV, Tishchenko IS. Endovaskulyarnaya revaskulyarizatsiya u patsientov s gnojno-nekroticheskimi ranami nizhnikh konechnostej s infraingvinal’nym protyazhennym porazheniem arterial’nogo rusla. Khirurgiya. Zhurnal im. N.I. Pirogova. 2020;9:102-108.  https://doi.org/10.17116/hirurgia2020091102
  20. Kurianov P, Lipin A, Antropov A, et al. Popliteal Artery Angioplasty for Chronic Total Occlusions with versus without the Distal Landing Zone. Annals of Vascular Surgery. 2020;68:417-425.  https://doi.org/10.1016/j.avsg.2020.04.054

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.